Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies
New England Journal of Medicine · 10.08.2023 · 389 (6) · 574-577
DOI: 10.1056/nejmc2307721 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 10.08.2023. Verfasst von Theodore E Warkentin und 6 weiteren Autor:innen. Beteiligte Einrichtung: McMaster University, Hamilton, ON, Canada twarken@mcmaster.ca. Hauptthemen laut MEDLINE: Adenoviridae Infections, Thrombocytopenia, Thrombosis, Adenovirus Vaccines. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- McMaster University, Hamilton, ON, Canada twarken@mcmaster.ca.
- University of North Carolina School of Medicine, Chapel Hill, NC.
- Bon Secours Cancer Institute, Richmond, VA.
- McMaster University, Hamilton, ON, Canada.
ORCID-Profile: Theodore E Warkentin
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Warkentin, T. E., Baskin-Miller, J., Raybould, A. L., Sheppard, J. I., Daka, M., Nazy, I., & Moll, S. (2023). Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies. New England Journal of Medicine, 389(6), 574-577. https://doi.org/10.1056/nejmc2307721
Vancouver
Warkentin TE, Baskin-Miller J, Raybould AL, Sheppard JI, Daka M, Nazy I, et al. Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies. New England Journal of Medicine. 2023;389(6):574-577. doi:10.1056/nejmc2307721
BibTeX
@article{Warkentin2023,
author = {Warkentin, Theodore E and Baskin-Miller, Jacquelyn and Raybould, Alison L and Sheppard, Jo-Ann I and Daka, Mercy and Nazy, Ishac and Moll, Stephan},
title = {Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {6},
pages = {574--577},
doi = {10.1056/nejmc2307721}
}
EUVIMED